Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001104659-18-016854
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-03-12 20:32:24
Reporting Period:
2018-02-28
Accepted Time:
2018-03-12 20:32:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
722830 Immunomedics Inc IMMU In Vitro & In Vivo Diagnostic Substances (2835) 611009366
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1029578 M David Goldenberg C/o Immunomedics, Inc
300 The American Road
Morris Plains NJ 07950
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-03-07 20,000 $17.50 1,774,285 No 4 S Direct
Common Stock Disposition 2018-02-28 17,729 $17.09 5,693,252 No 4 S Indirect See Footnote
Common Stock Disposition 2018-03-05 20,000 $17.30 5,673,252 No 4 S Indirect See Footnote
Common Stock Disposition 2018-03-05 20,000 $17.17 5,653,252 No 4 S Indirect See Footnote
Common Stock Disposition 2018-03-07 20,000 $17.60 5,633,252 No 4 S Indirect See Footnote
Common Stock Disposition 2018-03-07 20,000 $17.75 5,613,252 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
Footnotes
  1. Such shares were held by the reporting person's spouse, Ms. Cynthia L. Goldenberg, also known as Cynthia L. Sullivan.
  2. Includes a total of 635,935 shares held as joint tenants by the reporting person and his spouse, Ms. Cynthia L. Goldenberg, also known as Cynthia L. Sullivan, a director of the Company.
  3. Such shares are held by the reporting person's spouse, by various trusts established for the benefit of the reporting person and/or family members of the reporting person, or by a majority-owned subsidiary of the Issuer. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interests therein.